Thermo Fisher Scientific Inc (NYSE:TMO) Shorts Increased By 9.35% As Of Jun 27, 2018

June 27, 2018 - By Daniel Cummings

Thermo Fisher Scientific Inc. (NYSE:TMO) Corporate Logo

Big Money Sentiment decreased to 0.86 in 2018 Q1. It has change of 0.05, from 2017Q4’s 0.91. The ratio is negative due to Thermo Fisher Scientific Inc. positioning: 42 sold and 444 reduced. 119 funds acquired holdings and 301 increased holdings. Investors holded 335.65 million in 2017Q4 but now own 331.98 million shares or 1.09% less.
Moreover, Campbell Newman Asset has 0.17% invested in Thermo Fisher Scientific Inc. (NYSE:TMO). 22,086 were reported by Gateway Investment Advisers. Boston Private Wealth Ltd Company reported 6,091 shs. Alphaone Investment Services Llc has 0.05% invested in Thermo Fisher Scientific Inc. (NYSE:TMO). Kbc Nv owns 250,338 shs. Mu Invs Ltd invested 4.32% in Thermo Fisher Scientific Inc. (NYSE:TMO). Hancock Holdings owns 0.56% invested in Thermo Fisher Scientific Inc. (NYSE:TMO) for 61,007 shs. 633,928 are owned by Rhumbline Advisers. Fiduciary Communications has invested 0.6% in Thermo Fisher Scientific Inc. (NYSE:TMO). Seatown Hldgs Pte Ltd owns 128,600 shs for 2.52% of their capital. Intl Limited Ca reported 15,199 shs. Fisher Asset Management Limited holds 0% or 1,910 shs in its capital. Legal General Grp Pcl holds 1.85M shs. Banque Pictet And Cie Sa owns 1.55% invested in Thermo Fisher Scientific Inc. (NYSE:TMO) for 357,707 shs. Argent reported 0.64% stake.

Thermo Fisher Scientific Inc. had 11 sales and 0 insider purchases since February 2, 2018. This’s net activity of $48.68 million. On Wednesday, February 7 Williamson Stephen also sold $1.05M worth of Thermo Fisher Scientific Inc. (NYSE:TMO). On Wednesday, March 21 Shares for $16.94 million were sold by CASPER MARC N. On Thursday, February 15 a trade for 1,000 shs valued at $209,796 was made by Parrett William G. On Friday, February 2 Herrema Gregory J. sold $7.32 million worth of Thermo Fisher Scientific Inc. (NYSE:TMO) or 33,327 shs. On Friday, May 18 $44,174 worth of Thermo Fisher Scientific Inc. (NYSE:TMO) was sold by HARRIS C MARTIN.

Change of 9.35% for Thermo Fisher Scientific Inc (NYSE:TMO)’s shares shorted was reported. FINRA issued in June TMO’s total 4.82 million shares shorted. The up change of 9.35% from 4.41 million shares was reported. Former TMO’s position will need 3 days to restore. It has 1.55 million average volume.

TMO is reaching $205.15 during the last trading session, after increased 0.11%.Currently Thermo Fisher Scientific Inc. is uptrending after 23.57% change in last June 27, 2017. TMO has 946,309 shares volume. TMO outperformed by 11.00% the S&P 500.

Thermo Fisher Scientific Inc. provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacturing, analysis, discovery, and diagnostics under Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, and Unity Lab Services brands worldwide.The firm is valued at $82.54 billion. The Company’s Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of new drugs and vaccines, as well as diagnosis of diseases to pharmaceutical, biotechnology, agricultural, clinical, academic, and government markets.36.48 is the P/E ratio. The Company’s Analytical Instruments segment offers instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories.

Thermo Fisher Scientific Inc. (NYSE:TMO) Ratings Coverage

In total 9 analysts cover Thermo Fisher (NYSE:TMO). “Buy” rating has 8, “Sell” are 0, while 1 are “Hold”. 89% are bullish. With $250 highest and $216 lowest target price Thermo Fisher has $233.33 average target price or 13.74% above the current ($205.15) price. 12 are the (NYSE:TMO)’s analyst reports since January 3, 2018 according to StockzIntelligence Inc. The stock rating was maintained by Leerink Swann with “Buy” on Thursday, February 1. The company rating was maintained by Robert W. Baird on Thursday, January 18. On Thursday, February 1 the firm has “Hold” rating given by Jefferies. On Thursday, February 1 the firm has “Overweight” rating given by Barclays Capital. The stock rating was initiated by Evercore with “Buy” on Wednesday, January 3. On Wednesday, January 31 the firm has “Buy” rating by Robert W. Baird given. On Thursday, February 1 the firm earned “Overweight” rating by Morgan Stanley. On Thursday, February 1 the firm has “Buy” rating by Bank of America given. On Wednesday, April 11 the rating was maintained by Morgan Stanley with “Overweight”. On Wednesday, January 31 Cowen & Co maintained Thermo Fisher Scientific Inc. (NYSE:TMO) rating. Cowen & Co has “Buy” rating and $220.0 target.

For more Thermo Fisher Scientific Inc. (NYSE:TMO) news posted briefly go to: Globenewswire.com, Gurufocus.com, Seekingalpha.com, Prnewswire.com or Streetinsider.com. The titles are as follows: “Factors of Influence in 2018, Key Indicators and Opportunity within Dr Pepper Snapple Group, United Therapeutics …” posted on June 25, 2018, “Thermo Fisher Scientific Inc (TMO) CEO Marc N Casper Sold $9.7 million of Shares” on June 19, 2018, “Thermo Fisher launches Ion AmpliSeq HD technology” with a publish date: June 18, 2018, “Diagnostics Play Critical Role in Medical Sector” and the last “GE’s determined makeover could dim deal prospects” with publication date: June 26, 2018.

Thermo Fisher Scientific Inc. (NYSE:TMO) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.